Safety Evaluation Study for Patients With Polycythemia Vera

NCT05074550 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera

Interventions

DRUG: PPMX-T003

Sponsor

Perseus Proteomics Inc.